Dr. Norberto Guzman is currently Chief Scientific Officer at Princeton Biochemicals Inc., Princeton, New Jersey, U.S.A. Dr. Guzman’s expertise is primarily in biomedicine and biotechnology with emphasis in protein biochemistry and immunochemistry. At present, his main research interest is in the understanding of the function of newly-formed and/or post-translational-modified proteins in inflammatory processes, and the finding of therapeutic agents, such as natural and synthetic proteins/peptides, aimed to alleviate chronic inflammatory diseases. For several years, Dr. Guzman has developed immunoaffinity-analytical separation instrumentation and methodologies for the quantification, identification and characterization of proteins and peptides of relevance to the clinical laboratory, pharmaceutical industry and foodnutraceutical industry (e.g., erythropoietin, antibodies, and collagen). He also has used multiple crosslinking methods to generate scaffold of collagen with other natural or synthetic polymers to generate collagen-based biomaterials for use in tissue engineering applications or microencapsulation technology.
Dr. Guzman received a B.Sc. degree in biochemistry (clinical biochemistry) from a Joint Undergraduate Program of the University of Concepcion and the University of Chile, Santiago, Chile; a M.Sc. degree in biochemistry (cell and molecular biology) from the Medical College of Georgia, Augusta, Georgia, U.S.A.; and a Ph.D. degree in biochemistry (protein biochemistry) from a Joint Graduate Program of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School (formerly Rutgers Medical School) and Rutgers, The State University of New Jersey, New Brunswick, New Jersey, U.S.A. Dr. Guzman has worked for the last 30 years in academic medical institutions, diagnostic and pharmaceutical companies, including Mount Sinai School of Medicine, Roche Diagnostic Systems, Hoffman-La Roche, and Johnson & Johnson. He also has worked in a collagen food-nutraceutical industry. Dr. Guzman is the author or co-author of more than 130 scientific publications, including manuscripts, patents and book chapters. He has delivered over 300 oral presentations in Europe, the Americas, the Far East, and Australia. According to Google Scholar Citations, Dr. Guzman’s publications have been cited more than 5200 times, having an h-index of 38, and an i10 index of 69. One publication alone has more than 1300 citations. Nine figures of his publications have appeared on the front cover of prestigious scientific journals and books. One presentation at Google Headquarters in New York City has been viewed more than 1900 times (https://www.youtube.com/watch?v=1QnTrcYWk-o). He is the editor of 2 two widely referenced books on the subject of capillary electrophoresis and collagen prolyl hydroxylase.
Dr. Guzman holds numerous worldwide patents on capillary electrophoresis and microchip technology, and his accomplishments have been recognized by being the recipient of many national and international awards in science and technology innovation. Dr. Guzman is a member of several international scientific organizations. He serves on the editorial board of Electrophoresis (European journal), and the Journal of Liquid Chromatography and Related Technologies (American journal). Dr. Guzman is the founding editor of the Journal of Capillary Electrophoresis and Microchip Technology and one of the pioneers in this field. He is also the founder of the international symposia series known as LACE (Latin-American Capillary Electrophoresis).